My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

ResMed Inc. Common Stock (NY:RMD)

259.12 +2.83 (+1.10%)

Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Reasonable growth and debt and a high ROIC for RESMED INC (NYSE:RMD). ↗

September 09, 2024

Why NYSE:RMD Stands Out as a Quality Stock.

Via Chartmill

A Glimpse Into The Expert Outlook On ResMed Through 6 Analysts ↗

September 04, 2024

Via Benzinga

How Is The Market Feeling About ResMed? ↗

August 23, 2024

Via Benzinga

$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today ↗

August 20, 2024

Via Benzinga

RxSight Stock Sees Relative Strength Rating Rise To 91 ↗

August 19, 2024

On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91.

Via Investor's Business Daily

Why Quality-Oriented Investors Should Consider NYSE:RMD. ↗

August 19, 2024

Exploring RESMED INC (NYSE:RMD)'s quality characteristics.

Via Chartmill

NYSE:RMD may be ready to breakout. ↗

August 09, 2024

There are signs that NYSE:RMD may be ready to breakout.

Via Chartmill

Uncovering Dividend Opportunities with NYSE:RMD. ↗

August 09, 2024

Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing?

Via Chartmill

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,500 Today ↗

August 07, 2024

Via Benzinga

ResMed's Options Frenzy: What You Need to Know ↗

July 30, 2024

Via Benzinga

DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio? ↗

August 04, 2024

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H....

Via Benzinga

ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities ↗

August 02, 2024

ResMed reported Q4 2024 revenue of $1.22 billion, driven by strong demand for sleep devices and software services. Gross margin improved significantly due to reduced costs and higher selling prices....

Via Benzinga

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today ↗

July 26, 2024

Via Benzinga

Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday ↗

July 23, 2024

Via Benzinga

What 6 Analyst Ratings Have To Say About ResMed ↗

July 23, 2024

Via Benzinga

Looking Into ResMed's Recent Short Interest ↗

July 09, 2024

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,600 Today ↗

July 02, 2024

Via Benzinga

Stock Market News From Amazon, Nike, McCormick, and More ↗

July 08, 2024

We also talk with author Nicola Twilley about her new book, "Frostbite: How Refrigeration Changed Our Food, Our Planet, and Ourselves."

Via The Motley Fool

Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts ↗

July 05, 2024

Uncover key insights on stocks with negative analyst sentiment, including major moves by Alphabet, Nike and ResMed.

Via InvestorPlace

How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You? ↗

July 02, 2024

We also talk about weight loss drugs and sleep apnea, and other stock market news.

Via The Motley Fool

Is NYSE:RMD a Good Fit for Dividend Investing? ↗

July 01, 2024

Uncovering Dividend Opportunities with RESMED INC (NYSE:RMD).

Via Chartmill

Sound Investments: 3 Stocks to Buy for a Good Night’s Rest ↗

June 29, 2024

The safe stocks to buy for a good night’s rest aren’t the kind you’re thinking about. Nonetheless, they do make worthwhile investments.

Via InvestorPlace

Beyond The Numbers: 6 Analysts Discuss ResMed Stock ↗

June 25, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 26, 2024

Via Benzinga

Why ResMed Shares Are Trading Lower Monday ↗

June 24, 2024

ResMed stock is trading lower Monday after Eli Lilly and Company released data from a clinical trial in regards to the treatment of sleep apnea.

Via Benzinga

ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday ↗

June 24, 2024

Via Benzinga

Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday? ↗

June 24, 2024

Wall Street faces a continuation of last week’s trend during Monday’s morning trading, with semiconductor stocks selling off heavily and dragging down the tech sector, while the broader market remains...

Via Benzinga

Topics Stocks

Stocks Mixed As Investors Take Big Tech Profits ↗

June 24, 2024

The major benchmarks are mixed today, as investors cycle out of the outperforming tech sector and buy into bank and energy stocks.

Via Talk Markets

Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again ↗

June 24, 2024

Eli Lilly tested its weight-loss drug in people with obesity suffering from sleep apnea events.

Via Investor's Business Daily

Nasdaq Futures Slip As Nvidia Sell-Off Continues, S&P 500 Futures Hold Up: Analyst Says 'Valuations Will Go Parabolic And It Will Be A Perfect Time To Sell' ↗

June 24, 2024

The U.S.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.